Key Record Dates
ClinicalTrials.gov Identifier: | NCT04649359 |
---|---|
Brief Title: | MagnetisMM-3: Study Of Elranatamab (PF-06863135) Monotherapy in Participants With Multiple Myeloma Who Are Refractory to at Least One PI, One IMiD and One Anti-CD38 mAb |
First Submitted : | November 6, 2020 |
First Submitted that Met QC Criteria : | November 24, 2020 |
First Posted : | December 2, 2020 |
Results First Submitted : | June 15, 2023 |
Results First Posted with QC Comments : | July 10, 2023 |
Results First Submitted that Met QC Criteria : | October 4, 2023 |
Results First Posted : | October 25, 2023 |
Last Update Submitted that Met QC Criteria : | April 26, 2024 |
Last Update Posted : | April 30, 2024 |